Insights Into Urothelial Cancer 2024

Perspectives on drivers in treatment decisions in the management of urothelial cancer

Northeast – August 24, 2024
Purchase Report

Faculty Chair

David Aggen, MD, PhD

Memorial Sloan Kettering Cancer Center, New York, NY, USA

California – October 12, 2024
Purchase Report

Faculty Chair

Evan, YU, MD

Fred Hutchinson Cancer Center, Seattle, WA, USA

More Information

  • Philadelphia, PA
  • Connecticut, Delaware, District of Columbia, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont

More Information

  • Philadelphia, PA
  • Connecticut, Delaware, District of Columbia, Maine, Massachusetts, Maryland, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A virtual, moderated roundtable discussion focusing on the treatment of urothelial cancer
  • Disease state and data presentations are developed in conjunction with a national or regional oncology expert

GEOGRAPHIC REPRESENTATION AND CONTENT DEVELOPMENT

  • Data collection is accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors comprises 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.